PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 297.6K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
54.58
ESG score 90-95% of AXSM's 58.49. Bill Ackman would demand clear ESG improvement catalysts.
49.62
Environmental score 90-95% of AXSM's 54.45. Bill Ackman would demand clear environmental improvement catalysts.
57.51
Social score 90-95% of AXSM's 62.70. Bill Ackman would demand clear social improvement catalysts.
56.60
Similar governance score to AXSM's 58.33. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.